Multi-omics integrated analysis study on the relationship and mechanism between zinc deficiency and cardiovascular disease

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200064095

Enrollment

Unknown

Registered

2022-09-26

Start date

2022-10-01

Completion date

Unknown

Last updated

2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Zinc deficiency and cardiovascular disease

Interventions

Acute myocardial infarction zinc supplement intervention group:Zinc gluconate oral liquid 10ml, zinc content about 5mg/d

Acute myocardial infarction placebo group:Equal volume glucose oral liquid

Eligibility

Sex/Gender

All

Age

60 Years to 74 Years

Inclusion criteria

Inclusion criteria: 1. Adult residents aged 60-74 (considering the impact of living place on dietary habits, the respondents are required to live in different places for 10 years). 2. Participate voluntarily and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Aortic dissection, 2. Acute pericarditis, 3. Acute, chronic or infectious diseases, 4. Acute pulmonary embolism, 5. Pneumothorax and digestive tract diseases, acute cholecystitis.

Design outcomes

Primary

Measure	Time frame
Electrocardiogram;Cardiac imaging examination;Troponin;Myocardial enzymes;Serum zinc;Liver and kidney function;C-reactive protein;Hemogram;Fasting blood glucose;High density lipoprotein;Low density lipoprotein;	—

Countries

China

Contacts

Public ContactMaoqing Wang

wang_maoqing@126.com0451-87502876

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026